Understanding how inflammation resolves — and what happens when it doesn't.
Inflammation is a fundamental biological process. It is one of the body's primary responses to injury, physical stress, and infection.
In its acute form, inflammation helps coordinate tissue maintenance, immune surveillance, and recovery-related biological processes. Research has established that without an appropriate inflammatory response, normal tissue repair mechanisms would be significantly impaired.
The challenge is not inflammation itself. The challenge arises when inflammation fails to resolve.
Studies indicate that chronic low-grade inflammation is associated with a wide range of conditions, including persistent discomfort syndromes, metabolic dysfunction, neurodegenerative disorders, and age-related physiological decline. Researchers increasingly view chronic inflammation not as a continuously active version of acute inflammation, but as a breakdown in the body's normal resolution mechanisms.
Understanding that distinction is essential for understanding recovery biology.
Acute inflammation follows a highly coordinated and generally self-limiting sequence.
Resident immune cells, including macrophages and mast cells, detect tissue stress, cellular damage, or invading pathogens through specialized pattern-recognition systems.
Local blood vessels temporarily dilate and become more permeable. This allows plasma proteins and immune cells to move from the circulation into surrounding tissues. The visible signs often associated with acute inflammation — redness, warmth, swelling, and discomfort — reflect these vascular changes.
Neutrophils, often described as first-response immune cells, arrive within minutes to hours. These cells help remove cellular debris and participate in the body's early defense mechanisms.
Within approximately 24–48 hours, monocytes migrate into affected tissues and differentiate into macrophages. As the response progresses, macrophages typically transition from an inflammatory phenotype (M1) toward a resolution-oriented phenotype (M2).
This final phase is active — not passive. Specialized pro-resolving mediators (SPMs) — including resolvins, protectins, and maresins — are synthesized from omega-3 fatty acids. These molecules help coordinate the orderly conclusion of the inflammatory response.
Macrophages remove apoptotic neutrophils through a process known as efferocytosis, while signaling molecules such as IL-10 and TGF-β become increasingly dominant. Research suggests that every stage of this sequence requires substantial cellular energy. Immune-cell migration, phagocytosis, mediator synthesis, and efferocytosis are all ATP-dependent biological processes.
Emerging evidence suggests that chronic inflammation represents a distinct biological state rather than simply inflammation that lasts longer. Several mechanisms may contribute.
Under normal conditions, macrophages shift from M1 inflammatory activity toward M2 resolution-associated activity. Studies indicate that this transition may become impaired in chronic inflammatory environments. When this occurs, macrophages continue producing cytokines such as TNF-α, IL-1β, and IL-6, contributing to ongoing inflammatory signaling.
SPM synthesis depends on adequate substrates, enzymatic activity, and metabolic support. Researchers are exploring how nutritional status, metabolic dysfunction, and genetic variability may influence these pathways.
The removal of dying cells is a critical component of inflammatory resolution. When efferocytosis becomes inefficient, apoptotic cells may accumulate and eventually release intracellular contents into surrounding tissues. This can amplify inflammatory signaling and create a self-perpetuating cycle.
In some situations, the original trigger never fully disappears. Ongoing metabolic stress, autoimmune activity, chronic infection, impaired microcirculation, or prolonged cellular energy deficits may continuously stimulate inflammatory pathways. Research suggests that these persistent stressors can make resolution increasingly difficult over time.
Neuroinflammation refers to inflammatory activity within the nervous system. This remains an area of active investigation, particularly in relation to persistent discomfort conditions and neurological health.
The central nervous system contains specialized immune cells called microglia. Under normal conditions, microglia continuously monitor their environment. When exposed to injury signals, ischemia, systemic inflammatory signals, or cellular stress, microglia can activate.
Activated microglia may:
Studies have identified microglial activation within the spinal cord and brain in several persistent discomfort conditions. Researchers have observed associations between activated microglia and:
Importantly, some evidence suggests that neuroinflammatory processes may persist even after the original triggering event has resolved. This remains an active area of scientific investigation.
The transition from M1 to M2 macrophage activity is considered one of the most important regulatory processes in inflammation biology. Research suggests that successful inflammatory resolution depends on this shift.
Several approaches have been investigated.
In an animal study published in Advanced Science (IF 15.1), researchers reported that graphene FIR exposure was associated with increased Nr4a2 expression in peritoneal macrophages. Under the study conditions, investigators observed M2 polarization and reported a 67% reduction in post-surgical adhesions. A separate animal study reported similar observations in a diabetic tissue-repair model, where investigators documented 83.9% closure compared with 66.8% in controls. These findings are encouraging but should be interpreted within the context of their specific study designs.
Studies consistently indicate that regular physical activity influences immune-cell behavior and may support a shift toward resolution-associated macrophage activity.
Omega-3 fatty acids provide substrates for specialized pro-resolving mediator synthesis. Polyphenols and flavonoids have also been studied for their influence on inflammatory signaling pathways.
Research suggests that inadequate sleep may increase markers associated with inflammatory activity. Conversely, restorative sleep appears to support physiological adaptation and normal immune regulation.
Inflammation rarely operates in isolation. Researchers increasingly describe a three-way relationship involving inflammation, microcirculation, and mitochondrial function.
Chronic Inflammation
↓ may impair endothelial function
Microcirculatory Dysfunction
↓ may reduce oxygen and nutrient delivery
Mitochondrial ATP Depletion
↓ may limit cellular energy availability
Reduced Resolution Capacity
↓ may contribute to ongoing inflammatory signaling
Cycle Continues
Research suggests that these systems continuously influence one another. Microcirculation supports oxygen and nutrient delivery. Mitochondria convert those resources into ATP. ATP powers the biological processes required for inflammatory resolution. When one component becomes compromised, stress may propagate throughout the entire system. For this reason, many researchers view recovery biology through a systems-based lens rather than focusing on a single pathway.
What is the difference between acute and chronic inflammation?
Acute inflammation is a coordinated, self-limiting biological response that typically resolves after its objective has been achieved — usually within hours to days. It produces visible signs such as redness, warmth, and swelling. Chronic inflammation persists for months or years and represents a failure of resolution mechanisms. Studies suggest that chronic inflammation often involves failed macrophage transitions (M1→M2), insufficient specialized pro-resolving mediator activity, and ongoing biological stressors that prevent the system from returning to baseline.
What do studies suggest about neuroinflammation?
Research suggests that activated microglia — the central nervous system's resident immune cells — can release pro-inflammatory cytokines (IL-1β, TNF-α) and reactive oxygen species that influence neuronal signaling. Observed associations have been reported in several persistent discomfort conditions, including fibromyalgia and neuropathic pain, where microglial activation has been documented in the spinal cord and brain. The precise mechanisms remain an active area of investigation, though some evidence suggests neuroinflammatory processes may persist even after the original triggering event has resolved.
What is the M1-to-M2 macrophage transition?
Macrophages can adopt different functional states along a spectrum. M1 macrophages participate in early inflammatory responses — fighting infection and clearing debris. M2 macrophages are associated with resolution and tissue maintenance. Studies indicate that successful inflammatory resolution depends on a shift from M1 to M2 activity. When this transition fails — as observed in chronic inflammatory conditions — macrophages remain in a pro-inflammatory state, continuously releasing cytokines (TNF-α, IL-1β, IL-6) that perpetuate the inflammatory environment.
Understanding inflammation requires looking beyond symptoms and examining the biological systems that support resolution.
ATP Depletion and Pain Signaling →